Related Experiment Video
Updated: Jun 6, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Discordance between observer and patient-reported shared decision-making in inflammatory bowel disease: A multicenter
Eman S Al Sulais1, Mohammmed A AlBesher2, Zahra A Al Saeed1
1Gastroenterology Division, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Background:
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder affecting the gastrointestinal tract. Optimal management of this condition requires collaboration between patients and physicians, a process known as shared decision-making (SDM). In this study, we aim to evaluate the quality of SDM in gastroenterology clinics in the Eastern Province of Saudi Arabia.
Methods:
This multicenter, cross-sectional study was conducted between September 2024 and December 2025. Audio recordings of gastroenterology visits were independently assessed by two reviewers using the validated Observing Patient Involvement in Decision-Making (OPTION-5) scale. Moreover, patients evaluated their encounters using the 9-item SDM Questionnaire (SDM-Q-9). A multivariable regression analysis was performed to determine independent predictors of SDM from both the patient and physician perspectives.
Results:
A total of 105 encounters from three hospitals were analyzed with a median OPTION-5 score of 5 out of 100 (IQR 0-10). A multivariate linear regression analysis showed that longer consultation duration in minutes ( β = 1.88, 95% Confidence Interval (CI): 0.21-3.56, P = 0.028) and the decision to start a new medication ( β = 24.86, 95% CI: 17.24-32.48, P < 0.001) were independently associated with higher total OPTION-5 scores. There was no significant correlation between observer-rated OPTION-5 scores and patient-reported SDM-Q-9 scores (Spearman's ρ = -0.044, P = 0.687), indicating discordance between externally assessed and patient-perceived shared decision-making.
Conclusion:
In this cohort of patients with IBD from three centers in the Eastern Province of Saudi Arabia, observer-rated SDM was low. Multiple factors were significantly associated with the level of SDM, including longer consultation duration and decision to start new medication. Further studies to determine interventions that can enhance SDM are warranted.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
